 Good morning and welcome back to Investor Intel for a very special guest. I'm Peter Clausey. We're here with Mike Druhan from MedX Health. MedX Health sells a product and a service in an area of life that's touched us all and is important for all of us to hear this story. Welcome Mike. Oh, welcome Peter. MedX attacks health skin cancer. We've all been touched in some way in our lives by skin cancer. How many people around the world get skin cancer annually? Well, the WHO's sort of results are around about 140 million people are at risk of skin cancer. The numbers vary because of the registry and the way the numbers are collected, but it's a large swath of the population are susceptible to skin cancer. And I read somewhere that like 80% of all skin cancer is within two inches of the eyes. Interesting statistic, not aware of that one, but most of it happens around the head, neck, shoulders where you get the most amount of sun exposure. Did UVA weight it, UVA related? So anything around the eyes, around the neck, around the shoulders head, that's where it tends to show. Right. And your area of service is you sell, I call it a box, and then you sell data services so that box can be used intelligently. What does your box do? So our system is a proper SAS model. We have an optical scanner that will take an image of a molar lesion that is suspicious, our differentiators, it goes two millimeters below the skin, therefore taking a perfect view not only on the surface, but below the skin. And then we have a telemedicine platform that will send that information on the patient's health information along with the image to a dermatologist for proper assessment. So you sell the box and then you sell the data services after for recurring revenue? Correct. The box isn't just a single use, it's a multi-use box, like an ultrasound at a clinic. Yeah. It's not a one and done product. It's a repetitive product, and that's where the sustainability of the business model is, is every time a scan is taken, we're making revenue from that at a much reduced price of the cost of building hardware. Is it a handheld box or is it a box? It's a handheld device. So the scope itself is handheld. It just is on your hand, goes on top of the molar lesion, shuts out any ambient light coming in, takes a perfect focal image, but also goes two millimeters below the skin. So it's really important as it relates to giving additional information to a dermatologist who's not there to view the image. And this morning I was reading that you have some extremely large news to announce. Yeah. We've just put out news that we've received an order from our Brazilian partners for over 500 scopes to be the initial starting order in Brazil. This is the largest single order in the company's history. So we're pretty proud of that. What's the adult value of that initial order? Well, I'll give you some guidelines on that. The initial hardware order is close to a million dollars on the revenue take from that. And then once the images are starting to come on stream and the devices are deployed, you know, we'll get anywhere between 1.6 million a year to 2 million a year from ongoing revenue from that. I assume you have other letters of intent, soft contracts in the works that will lead up to POs with other areas? Oh yeah, we're we've been busy. You know, the technology is being well received. The telemedicine platform is what's been the newest sort of addition to the family. We've got the scanner for wire, but the Dermsecure platform now allows us to be scalable. And Brazil is the first order that we've received on the large scale platform. And I think that's going to show the marketplace that we're infinitely scalable and there's demand for the product. So we're pretty excited about this order. Where are your units manufactured? So right now we have a what they call an ISO 13485 facility right in Mississauga. And we produce our manufacturer devices there. However, with the scale of which we're starting to ramp to, we're starting to work with a third party manufacturer now to keep up with demand. So currently your expenses are being generated in Canadian dollars, which are probably selling internationally in US dollars. Correct. That's a nice margin in there as well. Well, as long as everything holds the way it is, we'll be quite happy. Excellent. New story to me. This is an important story that more people should hear about. Tracy, thank you for giving everyone a chance to hear it. Mike, thank you for your time. Peter, thank you so much for your time. Mad X. Have a look.